Tokyo, March 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061038) titled 'Effectiveness of Guideline for Dissemination and Education in Psychiatric Treatment: Phase 2' on March 24.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Department of Psychiatry, Dokkyo Medical University School of Medicine
Condition:
Condition - psychiatrists treating patients with schizophrenia and depression
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To conduct nationwide educational lectures based on guidelines for psychiatric care and to examine the effect of the guidelines.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Educational lectures of Japanese treatment guidelines for schizophrenia and depression
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Psychiatrists treating patients with schizophrenia and depression
Key exclusion criteria - non-psychiatrist
Target Size - 100
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 07 Month 30 Day
Date of IRB - 2025 Year 08 Month 30 Day
Anticipated trial start date - 2025 Year 09 Month 01 Day
Last follow-up date - 2031 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069850
Disclaimer: Curated by HT Syndication.
